<code id='B02371BFB5'></code><style id='B02371BFB5'></style>

<acronym id='B02371BFB5'></acronym>

<center id='B02371BFB5'><center id='B02371BFB5'><tfoot id='B02371BFB5'></tfoot></center><abbr id='B02371BFB5'><dir id='B02371BFB5'><tfoot id='B02371BFB5'></tfoot><noframes id='B02371BFB5'>

<optgroup id='B02371BFB5'><strike id='B02371BFB5'><sup id='B02371BFB5'></sup></strike><code id='B02371BFB5'></code></optgroup>

<b id='B02371BFB5'><label id='B02371BFB5'><select id='B02371BFB5'><dt id='B02371BFB5'><span id='B02371BFB5'></span></dt></select></label></b><u id='B02371BFB5'></u>

~~<i id='B02371BFB5'><strike id='B02371BFB5'><tt id='B02371BFB5'><pre id='B02371BFB5'></pre></tt></strike></i>~~

Home» knowledge» comprehensive

comprehensive

comprehensive

author：fashion 2025-09-29 04:02:00 Page View：7

Editor’s note: A livestream of the event will be embedded below at 1 p.m. ET.

How do we ensure the population in a study best reflects the people who will get a medicine in the real world?

advertisement

STAT will bring together a panel of leading experts to discuss the best solutions-based approaches.

Featured speakers:

LaShell Robinson,senior director, head of diversity, equity & inclusion in clinical research, Takeda
Ramita Tandon, chief clinical trials officer, Walgreens
Vindell Washington, M.D., M.S., MS.c, chief clinical officer of care and director of Health Equity Center of Excellence, Verily
Nicholas St. Fleur, general assignment reporter; associate editorial director of events, STAT (moderator)
Jennifer Cullingford, vice president, customer success, OneStudyTeam (sponsor speaker)

Sponsored By

Previous article： Drug firms test therapies to halt Alzheimer’s before symptoms arise
Next article： State Dept. review finds Biden bears some blame for Afghanistan failures

explore

Duchenne breakthrough therapy leaves behind pioneering families

Duchenne breakthrough therapy leaves behind pioneering families

DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

Eli Lilly expects to double planned employment in Boston center

Eli Lilly expects to double planned employment in Boston center

Anartist'srenderingofthebuilding—currentlyunderconstructionalongBoston'sFortPointChannel—whereEliLil

FDA approval of Sarepta Duchenne genetic therapy gives me hope

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Duchennemusculardystrophyhistopathology.Dr.EdwinP.Ewing,Jr./CDCWhenIwasdiagnosedwithDuchennemuscular

STAT Readout Newsletter: Today's biggest biotech updates

Photoillustration:STATWanttostayontopofthescienceandpoliticsdrivingbiotechtoday? Signup togetourbiot

read more